Progress in development of liver fluke vaccines

Parasitology Today

Volumn 14, Issue 6, 1998, Pages 224-228

  Spithill, T W ^a   Dalton, J P ^b  

^a MONASH UNIVERSITY   (Australia)

^b DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FASCIOLA HEPATICA VACCINE; UNCLASSIFIED DRUG; VACCINE;

ACTIVE IMMUNIZATION; FASCIOLA HEPATICA; FASCIOLIASIS; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; REVIEW; VACCINE PRODUCTION;

ANIMALIA; FASCIOLA; FASCIOLA HEPATICA; HEPATICA; PARALICHTHYS DENTATUS;

EID: 0031814263     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(98)01245-9     Document Type: Review

References (72)

1. Boray, J.C. (1985) in Parasites, Pests and Predators (Gaafar, S.M., Howard, W.E. and Marsh, E., eds), pp 179-218, Elsevier.
2. Fabiyi J.P. Production losses and control of helminths in ruminants of tropical regions. Int. J. Parasitol. 17:1987;435-442.
3. Boray J.C.et al. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Record. 113:1983;315-317.
4. Suhardonoet al. Control of Fasciola gigantica with triclabendazole in Indonesian cattle. Trop. Anim. Health Prod. 23:1991;217-220.
5. Overend D.J., Bowen F.L. Resistance of Fasciola hepatica to triclabendazole. Aust. Vet. J. 72:1995;275-276.
6. Rickard, M.D. and Howell, M.J. (1982) in Biology and Control of Ectoparasites (Symons, L.E.A., Donald, A.D. and Dineen, J.K., eds), pp 343-374, Academic Press.
7. Haroun E.M., Hillyer G.V. Resistance to fascioliasis - a review. Vet. Parasitol. 20:1986;63-93.
8. Hillyer G.V.et al. Schistosoma mansoni: acquired immunity in mice and hamsters using antigens of Fasciola hepatica. Exp. Parasitol. 42:1977;348-355.
9. Hillyer G.V. Schistosoma mansoni: reduced worm burdens in mice immunized with isolated Fasciola hepatica antigens. Exp. Parasitol. 48:1979;287-295.
10. Hillyer G.V.et al. Acquired resistance to Fasciola hepatica in cattle using a purified adult worm antigen. Am. J. Trop. Med. Hyg. 37:1987;363-369.
11. Hillyer G.V. Induction of immunity in mice to Fasciola hepatica with a Fasciola/Schistosoma cross-reactive defined immunity antigen. Am. J. Trop. Med. Hyg. 34:1985;1127-1131.
12. Hillyer G.V.et al. Successful vaccination against murine Schistosoma mansoni infection with a purified 12 kD Fasciola hepatica cross-reactive antigen. Am. J. Trop. Med. Hyg. 38:1988;103-110.
13. Rodriguez-Perez J.et al. Fasciola hepatica: molecular cloning, nucleotide sequence and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid binding protein. Exp. Parasitol. 74:1992;400-407.
14. Moser D.et al. A 14 kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. J. Biol. Chem. 266:1991;8447-8454.
15. Tendler M.et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual- purpose anti-helminth vaccine. Proc. Natl. Acad. Sci. U. S. A. 93:1996;269-273.
16. Smooker P.M.et al. Isolation, characterisation and expression of a cDNA encoding a Fasciola gigantica fatty acid binding protein. Exp. Parasitol. 85:1997;86-91.
17. Estuningsih, E. et al. Evaluation of antigens of Fasciola gigantica as vaccines against tropical fasciolosis in cattle. Int. J. Parasitol. (in press).
18. Muro A.et al. Fasciola hepatica: vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins. Vet. Parasitol. 69:1997;219-229.
19. Bozas S.E., Spithill T.W. Identification of 3- hydroxyproline residues in several proteins of Fasciola hepatica. Exp. Parasitol. 82:1996;69-72.
20. Janssen D., Barrett J. A novel lipid-binding protein from the Cestode Moniezia expansa. Biochem. J. 311:1995;49-57.
21. Brophy P.M., Pritchard D.I. Parasitic helminth glutathione S-transferases: an update on their potential as targets for immuno- and chemotherapy. Exp. Parasitol. 79:1994;89-96.
22. Precious W.Y., Barrett J. The possible absence of cytochrome P-450 linked xenobiotic metabolism in helminths. Biochim. Biophys. Acta. 992:1989;215-222.
23. Brophy P.M.et al. Relative distribution of glutathione S-transferase, glyoxylase I and glyoxylase II in helminths. Int. J. Parasitol. 20:1990;259-261.
24. Howell M.J.et al. Glutathione S-transferases in Fasciola hepatica. J. Parasitol. 74:1988;715-718.
25. Brophy P.M.et al. Detoxification reactions of Fasciola hepatica cytosolic glutathione transferases. Mol. Biochem. Parasitol. 39:1990;155-161.
26. Wijffels G.L.et al. Primary sequence heterogeneity and tissue expression of glutathione S-transferases of Fasciola hepatica. Exp. Parasitol. 74:1992;87-99.
27. Panaccio M.et al. Molecular characterization of cDNA sequences encoding glutathione S-transferases of Fasciola hepatica. Exp. Parasitol. 74:1992;232-237.
28. Muro A.et al. Sequence analysis of a Fasciola hepatica glutathione S-transferase cDNA clone. Am. J. Trop. Med. Hyg. 48:1993;457-463.
29. Creaney J.et al. Fasciola hepatica: localisation of glutathione S-transferase isoenzymes in adult and juvenile liver fluke. Exp. Parasitol. 81:1995;106-116.
30. Sexton J.L.et al. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep. J. Immunol. 145:1990;3905-3910.
31. Hillyer G.V.et al. Fasciola hepatica: host responders and non-responders to parasite glutathione S-transferase. Exp. Parasitol. 75:1992;176-186.
32. Morrison C.A.et al. Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine. 14:1996;1603-1612.
33. Howell R.M. Collagenase activity of immature Fasciola hepatica. Nature. 209:1966;713-714.
34. Halton D.W. Observations on the nutrition of digenetic trematodes. Parasitology. 57:1967;639-660.
35. Chapman C.B., Mitchell G.F. Proteolytic cleavage of immunoglobulin by enzymes released by Fasciola hepatica. Vet. Parasitol. 11:1982;165-178.
36. Dalton J.P., Heffernan M. Thiol proteases released in vitro by Fasciola hepatica. Mol. Biochem. Parasitol. 35:1989;161-166.
37. Rege A.A.et al. Isolation of a cysteine proteinase from Fasciola hepatica adult worms. Mol. Biochem. Parasitol. 35:1989;89-96.
38. Yamasaki H.et al. A cysteine proteinase from the liver fluke Fasciola spp.: purification, characterisation, localisation and application to immunodiagnosis. Jpn. J. Parasitol. 38:1989;373-384.
39. Yamasaki H., Aoki T. Cloning and sequence analysis of the major cysteine proteases expressed in the trematode parasite Fasciola spp. Biochem. Mol. Biol. Int. 31:1993;537-542.
40. McGinty A.et al. Characterisation of the cysteine proteinases of the common liver fluke Fasciola hepatica using novel, active site directed affinity labels. Parasitology. 106:1993;487-493.
41. Smith A.M.et al. Purification of a cathepsin L-like proteinase secreted by adult Fasciola hepatica. Mol. Biochem. Parasitol. 62:1993;1-8.
42. Dowd A.J.et al. Purification of a second cathepsin L proteinase secreted by the parasitic trematode Fasciola hepatica. Eur. J. Biochem. 223:1994;91-98.
43. Wijffels G.L.et al. Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity. Exp. Parasitol. 78:1994;132-148.
44. Wijffels G.L.et al. The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues. Biochem. J. 299:1994;781-790.
45. Heussler V.T., Dobbelaere D.A. Cloning of a protease gene family of Fasciola hepatica by the polymerase chain reaction. Mol. Biochem. Parasitol. 64:1994;11-23.
46. Yamasaki H.et al. Immunocytochemical localization of a cysteine protease in adult worms of the liver fluke Fasciola sp. Parasitol. Res. 78:1992;574-580.
47. Goose J. Possible role of excretory/secretory products in evasion of host defenses by Fasciola hepatica. Nature. 275:1978;216-217.
48. Carmona C.et al. Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. Mol. Biochem. Parasitol. 62:1993;9-18.
49. Smith A.M.et al. Fasciola hepatica: a secreted cathepsin L-like proteinase cleaves host immunoglobulin. Int. J. Parasitol. 23:1993;977-983.
50. Dowd A.J.et al. Fasciola hepatica cathepsin L proteinase cleaves fibrinogen and produces a novel type of fibrinogen clot. Eur. J. Biochem. 232:1995;241-246.
51. Beresain P.et al. Proteinases secreted by Fasciola hepatica degrade extracellular matrix and basement membrane components. J. Parasitol. 83:1997;1-5.
52. Wilson, L.R. et al. Fasciola hepatica: characterisation and cloning of the major cathepsin B protease secreted by newly excysted juvenile liver fluke. Exp. Parasitol. (in press).
53. Spithill, T.W. and Morrison, C.A. in Immunology, Pathophysiology and Control of Fasciolosis (Boray, J., ed.), MSD AGVET (in press).
54. Dalton J.P.et al. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect. Immun. 64:1996;5066-5074.
55. McGonigle S., Dalton J.P. Isolation of Fasciola hepatica haemoglobin. Parasitology. 111:1995;209-215.
56. Smith A.M.et al. Neutralization of the activity of a Fasciola hepatica cathepsin L proteinase by anti-cathepsin L antibodies. Parasite Immunol. 16:1994;325-328.
57. Mulcahy, G. et al. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine (in press).
58. Dalton, J.P. and Brindley, P.J. (1997) in Advances in Trematode Biology (Fried, B. and Graczyk, T.K., eds), pp 265-307, CRC Press.
59. Wasilewski M.M.et al. Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo. Mol. Biochem. Parasitol. 81:1996;179-189.
60. Tielens A.G.M.et al. The energy metabolism of Fasciola hepatica during its development in the final host. Mol. Biochem. Parasitol. 13:1984;301-307.
61. Mansour T.E. The effects of serotonin on phenol oxidase from the liver fluke, Fasciola hepatica, and other sources. Biochim. Biophys. Acta. 30:1958;492-500.
62. Dargie, J.D. (1986) in Proceedings of the 6th International Congress of Parasitology (Howell, M.J., ed.), pp 453-463, Australian Academy of Science.
63. Sahba G.H.et al. Animal fascioliasis in Khuzestan Southwestern Iran. J. Parasitol. 58:1972;712-716.
64. Schillhorn van Veen T.W.et al. Incidence of liver fluke infections (Fasciola gigantica and Dicrocoelium hospes) in ruminants in Northern Nigeria. Trop. Anim. Health Prod. 12:1980;97-104.
65. Lipps G.et al. Cathepsin B of Schistosoma mansoni; purification and activation of the recombinant proenzyme secreted by Saccharomyces cerevisiae. J. Biol. Chem. 271:1996;1717-1725.
66. Roche L.et al. Functional expression of Fasciola hepatica cathepsin L1 in Saccharomyces cerevisiae. Eur. J. Biochem. 245:1997;373-380.
67. Dowd A.J.et al. Isolation of a cDNA encoding Fasciola hepatica cathepsin L2 and functional expression in Saccharomyces cerevisiae. Mol. Biochem. Parasitol. 88:1997;163-174.
68. Salvatore L.et al. Biochemical analysis of recombinant glutathione S-transferase of Fasciola hepatica. Mol. Biochem. Parasitol. 69:1995;281-288.
69. McGonigle S.et al. Cloning of peroxiredoxin, a novel antioxidant from the helminth parasite Fasciola hepatica. Parasitology. 115:1997;101-104.
70. Tkalcevic J.et al. Fasciola hepatica: rapid switching of stage-specific antigen expression after infection. Parasite Immunol. 18:1996;125-132.
71. Lightowlers M.W. Vaccination against animal parasites. Vet. Parasitol. 54:1994;177-204.
72. Willadsen P.et al. Commercialisation of a recombinant vaccine against Boophilus microplus. Parasitology. 110:1995;S43-S50.